In this study, we evaluated the potential therapeutic role of AS1517499, a potent and selective STAT6 inhibitor (21), in myeloid fibroblast activation and development of renal fibrosis in two experimental murine models. The gene discussed is STAT6; the disease is renal fibrosis.